Skip to Content

GS WXG (Requip XL 4 mg)

Generic Name: ropinirole

Pill imprint GS WXG has been identified as Requip XL 4 mg.

Requip XL is used in the treatment of parkinson's disease; periodic limb movement disorder and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Requip XL 4 mg is not a controlled substance under the Controlled Substance Act (CSA).

Requip XL 4 mg GS WXG
Requip XL 4 mg GS WXG
Discount Card Promo
Requip XL
Generic Name:
ropinirole
Imprint:
GS WXG
Strength:
4 mg
Color:
Brown
Size:
13.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
GlaxoSmithKline
National Drug Code (NDC):
00007-4887
Inactive Ingredients:
carboxymethylcellulose sodium
silicon dioxide
glyceryl dibehenate
hydrogenated castor oil
hypromelloses
lactose monohydrate
magnesium stearate
maltodextrin
mannitol
povidone

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide